Masashi Kasajima

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study

Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara et al. · Clinical Lung Cancer · 2018 · 106 citations

Prognostic Biomarkers, Cancer Immunosurveillance, Lung Inflammation +9

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · PLoS ONE · 2019 · 39 citations · Full text

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · Cancer Management and Research · 2018 · 28 citations · Full text

Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer

Tomoya Fukui, Michiko Itabashi, Mikiko Ishihara et al. · BMC Cancer · 2016 · 27 citations · Full text

<p>Impact of <em>EGFR </em>genotype on the efficacy of osimertinib in <em>EGFR </em>tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study</p>

Satoshi Igawa, Taihei Ono, Masashi Kasajima et al. · Cancer Management and Research · 2019 · 23 citations · Full text